𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis

✍ Scribed by R. J. Reece; J. D. Canete; W. J. Parsons; P. Emery; D. J. Veale


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
203 KB
Volume
42
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

✦ Synopsis


To examine the macroscopic vascular pattern of early synovitis in psoriatic arthritis (PsA), reactive arthritis (ReA), and rheumatoid arthritis (RA) and to assess the reliability of the grading features for synovitis.

Methods. Forty-four patients (14 PsA, 12 ReA, and 18 RA) with knee synovitis who were undergoing arthroscopy were assessed. Video recordings of the examination were scored independently by 3 arthroscopists who were blinded to the patient's identity and clinical details. Features of vascularity, villous formation, pannus, granularity, and capillary hyperemia were recorded and kappa values (؊1< < 1) were calculated to assess interobserver reliability.

Results. The interobserver reliability between experienced observers was high ( > 0.8) for features of vascularity, villous hypertrophy, and pannus. Seventythree percent of the PsA and ReA patients had predominantly tortuous, bushy vessels; 89% of the RA patients had mainly straight, branching vessels.

Conclusion.

The distinct vascular patterns in PsA and ReA compared with those in RA may reflect different specific vascular factors in the pathogenesis of these arthritides. Vascularity and villous hypertrophy are the most reliable features of synovitis grading.


πŸ“œ SIMILAR VOLUMES


Comparison of ultrasonographic assessmen
✍ P. C. Taylor; A. Steuer; J. Gruber; D. O. Cosgrove; M. J. K. Blomley; P. A. Mars πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 163 KB πŸ‘ 2 views

## Objective: To investigate sensitive ultrasonographic imaging methods for detection of synovial thickness and vascularity to discriminate between patients with early rheumatoid arthritis (ra) receiving infliximab + methotrexate (mtx) versus placebo + mtx over 18 weeks, and to compare the relation

Very early treatment with infliximab in